Development of sustained-release devices for modulation of dental plaque biofilm and treatment of oral infectious diseases

Drug Development Research

Volumn 50, Issue 3-4, 2000, Pages 555-565

  Steinberg, Doron ^a   Friedman, Michael ^b,c  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY OF JERUSALEM   (Israel)

^c David R Bloom Center for Pharmacy   (Israel)

Author keywords

Dental biofilm; Dental caries; Dental sustained release delivery systems; Periodontal diseases

Indexed keywords

ANTIINFECTIVE AGENT; ANTIINFLAMMATORY AGENT; CHLORHEXIDINE; DOXYCYCLINE; FLUORIDE; METRONIDAZOLE; TETRACYCLINE;

BIODEGRADATION; BIOFILM; DENTAL CARIES; DEVICE; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM; FIBER; GEL; MOUTH INFECTION; PATIENT COMPLIANCE; PERIODONTIUM; REVIEW; SUSTAINED RELEASE PREPARATION; TOOTH PLAQUE;

EID: 0033819188     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2299(200007/08)50:3/4<555::AID-DDR39>3.0.CO;2-P     Document Type: Review

References (85)

1. The development and in vitro evaluation of acrylic strips and dialysis tubing for local drug delivery
2. Clinical responses to subgingival application of a metronidazole 25% gel compared to the effect of subgingival scaling in adult periodontitis
3. Comparison of the clinical effects of subgingival application of metronidazole 25% gel and scaling in the treatment of adult periodontitis
4. Nuclear magnetic resonance study of an ethyl cellulose sustained-release delivery system. II: Release rate behavior of tetracycline
5. Nuclear magnetic resonance study of an ethyl cellulose sustained-release delivery system. I: Effect of casting solvent on hydration properties
6. Development of sustained-release antimicrobial dental varnishes effective against Streptococcus mutans in vitro
7. The effect of local application of a sustained release delivery system of chlorhexidine on plaque accumulation
8. Local delivery of chlorhexidine
9. Experimental use of a slow release device employing chlorhexidine gluconate in areas of acute periodontal inflammation
10. The cost-effectiveness of a new chlorhexidine delivery system in the treatment of adult periodontitis
11. Enhancement of permeability of ethyl cellulose films for drug penetration
12. A modified placement technique to improve retention of tetracycline-impregnated fibers
13. The use of locally-delivered doxycycline in the treatment of periodontitis. Clinical results
14. Sustained release device containing minocycline for local treatment of periodontal disease
15. Effect of 6-monthly applications of chlorhexidine varnish on incidence of occlusal caries in permanent molars: A three years study
16. Evaluation of tetracycline fiber therapy with digital image analysis
17. New sustained release dosage form of chlorhexidine for dental use. I. Development and kinetics of release
18. Prevention of plaque accumulation by local application of sustained release delivery system of chlorhexidine
19. Plaque inhibition by sustained release of chlorhexidine from removable appliances
20. Inhibition of plaque formation by a sustained release delivery system for cetylpyridinium chloride
21. Structural and microbiological evaluation of a degradable sustained-release device for use in periodontal therapy
22. Sustained release device containing metronidazole for periodontal use
23. Antibiotic resistance of the subgingival microbiota following local tetracycline therapy
24. Periodontal therapy by local delivery of tetracycline
25. Monolithic tetracycline-containing fibers for controlled delivery to periodontal pockets
26. Local ofloxacin delivery using a controlled-release insert (PT-01) in the human periodontal pocket
27. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid matrices
28. Effect of repeated treatment with sustained-release chlorhexidine mouth guards on salivary levels of mutans streptococci
29. Effect of slow-release chlorhexidine mouthguards on the levels of selected salivary bacteria
30. Adjunctive use of a subgingival controlled-release chlorhexidine chip reduces probing depth and improves attachment level compared with scaling and root planing alone
31. The use of locally delivered chlorhexidine in the treatment of periodontitis. Clinical results
32. Assessing the effectiveness of locally delivered chlorhexidine in the treatment of periodontitis
33. Topical chemotherapy in human periodontitis using a new controlled-release insert containing ofloxacin. I. Microbiological observation
34. A six-month comparison of three periodontal local antimicrobial therapies in persistent periodontal pockets
35. Three regimens of topical metronidazole compared with subgingival scaling on periodontal pathology in adults
36. Inhibition of plaque formation and gingivitis in beagle dogs by topical use of a degradable controlled-release system containing chlorhexidine
37. Inhibition of plaque formation by local application of a degradable controlled release system containing cetylpyridinium chloride
38. Local tetracycline delivery using hollow fiber devices in periodontal therapy
39. Use of the polymeric matrix as internal standard for quantitation of in vivo delivery of tetracycline HCl from Actisite tetracycline fiber during periodontal treatment
40. The time and ease of placement of the chlorhexidine chip local delivery system
41. Response to intracrevicular controlled delivery of 25% tetracycline from poly(lactide/glycolide) film strips in SPT patients
42. Topical varnish containing strontium in sustained release device as treatment of dentine hypersensitivity
43. Retention, antimicrobial activity, and clinical outcomes following use of a bioerodible tetracycline gel in moderate-to-deep periodontal pockets
44. A 6-month multi-center evaluation of adjunctive tetracycline fiber therapy used in conjunction with scaling and root planing in maintenance patients: Clinical results
45. New method for local drug delivery using resorbable base material in periodontal therapy
46. Formulation of a drug delivery system based on a mixture of monoglycerides and triglycerides for use in the treatment of periodontal disease
47. A clinical and microbiological evaluation of systemic and local metronidazole delivery in adult periodontitis patients
48. Adjunctive systemic and locally delivered metronidazole in the treatment of periodontitis: A controlled clinical study
49. Comparative clinical and microbiological effects of topical subgingival application of metronidazole 25% dental gel and scaling in the treatment of adult periodontitis
50. Periodontal pocket treatment in beagle dogs using subgingival doxycycline from a biodegradable system. I. Initial clinical responses
51. Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. I. Study design, procedures, and management
52. Multi-center comparative evaluation of subgingivally delivered sanguinarine and doxycycline in the treatment of periodontitis. II. Clinical results
53. Serum levels of tetracycline during treatment with tetracycline-containing fibers
54. Repeated local metronidazole-therapy as adjunct to scaling and root planing in maintenance patients
55. Effects of smoking on local deliver of controlled-release doxycycline as compared to scaling and root planning
56. Sustained release of drugs from ethylcellulose-polyethylene glycol films and kinetics of drug release
57. Clinical trial in adults of an antimicrobial varnish for reducing mutans streptococci
58. Effects of varnishes containing chlorhexidine on the human dental plaque flora
59. In vitro assessment of the antimicrobial activity of a local sustained release device containing amine fluoride for the treatment of oral infectious diseases
60. The anticariogenic effect of amine-fluorides on Streptococcus sobrinus and glucosyltransferase in biofilms
61. Clinical and microbiological effects of chlorhexidine and arginine sustained-release varnishes in the mentally retarded
62. Subgingival microorganisms and bacterial virulence factors in periodontitis
63. Effects of subgingival chlorhexidine irrigation of periodontal inflammation
64. New sustained release dosage form of chlorhexidine for dental use. II. Use in periodontal therapy
65. Sustained local delivery of chlorhexidine in the treatment of periodontitis: A multi-center study
66. An in vivo study of the chlorhexidine release profile of the PerioChip in the gingival crevicular fluid, plasma and urine
67. Clinical and microbiological effects of sustained release chlorhexidine in periodontal pockets
68. Local application of sustained-release delivery system of chlorhexidine in Down's syndrome population
69. Sustained release degradable device of chlorhexidine: Structure, mechanism of release and clinical applications
70. Studying plaque biofilms on various dental surfaces
71. Antibacterial effect of chlorhexidine on bacteria adsorbed onto experimental dental plaque
72. A new degradable controlled release device for treatment of periodontal disease: In vitro release study
73. The effect of sustained-release varnish of chlorhexidine in plastic shells on salivary Streptococcus mutans
74. The effect of parabens in a mouth wash and incorporated into a sustained release varnish, on salivary bacteria
75. The effect of extracellular polysaccharides from Streptococcus mutans on the bactericidal activity of human neutrophils
76. Concentration of metronidazole in periodontal pockets after application of a metronidazole 25% dental gel
77. Elimination of Elyzol 25% dentalgel matrix from periodontal pockets
78. Systemic absorption of metronidazole after application of a metronidazole 25% dental gel
79. Zero-order delivery with periodontal placement of tetracycline-loaded ethylene vinyl acetate fibers
80. A controlled multicenter study of adjunctive use of tetracycline periodontal fibers in mandibular class II furcations with persistent bleeding
81. Microbiological and clinical short-term effects of repeated intracrevicular chlorhexidine rinsings
82. Microbiological response of localized sites with recurrent periodontitis in maintenance patients treated with tetracycline fibers
83. Intrapocket chemotherapy in adult periodontitis using a new controlled-release insert containing ofloxacin (PT-01)
84. The effect of sustained release application of chlorhexidine on salivary levels of Streptococcus rautans in partial denture wearers
85. Inhibition of plaque under periodontal dressing by sustained-release varnish of chlorhexidine